22 April 2025 - Real-world evidence is increasingly used and accepted by health technology assessment (HTA) bodies as supportive evidence ...
31 March 2025 - The aim of this policy article is twofold: (i) to provide a summary and update of recent ...
1 February 2025 - This paper investigates the current use of real world data for estimating relative treatment effects in NICE ...
12 December 2024 - Today, the US FDA’s Center for Drug Evaluation and Research (CDER) announced the new CDER Center ...
7 August 2024 - Canada’s Drug Agency has published a summary report from its time-limited Industry Task Force. ...
26 June 2024 - As part of the reauthorisation of the Prescription Drug User Fee Act (PDUFA VII), FDA committed ...
22 May 2024 - Today, COTA announced an extension of its research collaboration with the US FDA Oncology Center of Excellence. ...
15 May 2024 - Evidence about the comparative effects of new treatments is typically collected in randomised controlled trials (RCTs). In ...
15 February 2024 - The EMA and the Heads of Medicines Agencies have launched two public electronic catalogues: one for ...
22 November 2023 - The draft paper 'Optimising the availability and use of real world data and real world evidence to ...
30 August 2023 - Today, the US FDA issued a final guidance for industry titled Considerations for the Use of Real-World ...
18 August 2023 - CADTH is establishing an industry task force that will build upon the recently released guidance for reporting ...
27 June 2023 - Expanding ways to generate evidence can lead to an array of benefits for medical product development, including ...
23 June 2023 - Real world evidence from studies led by regulators can complement evidence from other sources including clinical trials. ...
31 May 2023 - CADTH has partnered with Health Canada, the Institut national d’excellence en santé et en services sociaux (INESSS), ...